Full Press Release Details
Immutep to Present at Healthcare Investor Conferences.
IMMP
Immutep to Present at Healthcare Investor Conferences
Key Takeaway: Immutep to Present at Healthcare Investor Conferences
Price reaction · baseline $2.52 (2022-02-22 close) · hit after-hours · 3 other IMMP headline(s) in the window, move may be shared
day 0 close
-1.6%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+76%
120-day peak, hindsight
Typical move
5.4%
average across 13 past catalysts
Lead asset
eftilagimod alfa
Phase 3 · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)